Therapeutic strategies in the treatment of periodontitis

Periodontitis is a chronic inflammatory process which affects the tooth supporting structures of the teeth. The disease is initiated by subgingival periopathogenic bacteria in susceptible periodontal sites. The host immune response towards periodontal pathogens helps to sustain periodontal disease and eventual alveolar bone loss. Although scaling and root planing is the standard treatment modality for periodontitis, it suffers from several drawbacks such as the inability to reach the base of deep pockets and doesn’t arrest migration of periodontal pathogens from other sites in the oral cavity. In order to overcome the limitations of scaling and root planning, adjunctive chemotherapeutics and host modulatory agents to the treatment are used. These therapeutic agents show substantial beneficial effects when compared to scaling and root planning alone. This review will cover an update on chemotherapeutic and past and future host immune modulatory agents used adjunctively to treat and manage periodontal diseases.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.33320/MACED.PHARM.BULL.2012.58.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement and dysbiosis in periodontal disease.

  2012cited by this paper
• Azithromycin in periodontal treatment: more than an antibiotic

  2012cited by this paper
• Minocycline hydrochloride nanoliposomes inhibit the production of TNF-α in LPS-stimulated macrophages

  2012cited by this paper
• Local and systemic antimicrobial therapy in periodontics.

  2012cited by this paper
• Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease

  2012cited by this paper
• Rheumatoid arthritis and periodontitis – inflammatory and infectious connections. Review of the literature

  2012cited by this paper
• Host Modulation in Periodontics

  2012cited by this paper
• Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration.

  2011cited by this paper
• Clarithromycin accumulation by phagocytes and its effect on killing of Aggregatibacter actinomycetemcomitans.

  2011cited by this paper
• Effect of inhaled corticosteroid on TNF-α production and alveolar bone loss in Wistar rats.

  2011cited by this paper
• Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans.

  2011influential reference
• Nonsurgical periodontal therapy combined with laser and photodynamic therapies for periodontal disease in immunosuppressed rats.

  2011cited by this paper
• A New Paradigm in Autoimmunity-Role In Periodontal Disease

  2011cited by this paper
• Comparison between laser therapy and non-surgical therapy for periodontitis in rats treated with dexamethasone

  2010cited by this paper
• Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases.

  2010influential reference
• Effect of intracanal corticosteroids on healing of replanted dog teeth after extended dry times.

  2009cited by this paper
• Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors.

  2009cited by this paper
• Non surgical periodontal therapy

  2009cited by this paper
• Treatment of oral inflammatory diseases with a new mucoadhesive prednisolone tablet versus triamcinolone acetonide paste.

  2009cited by this paper
• EFFECT OF BETAMETHASONE ON THE PULP AFTER TOPICAL APPLICATION TO THE DENTIN OF RAT TEETH: VASCULAR ASPECTS OF THE INFLAMMATION

  2009cited by this paper
• The management of inflammation in periodontal disease.

  2008cited by this paper
• Distribution of systemic clarithromycin to gingiva.

  2008cited by this paper
• Recent approaches for the treatment of periodontitis.

  2008cited by this paper
• The Management of Inflammation in Periodontal Disease

  2008cited by this paper
• Clarithromycin Transport by Gingival Fibroblasts and Epithelial Cells

  2008cited by this paper
• Effect of adjunctive systemic azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: a pilot study.

  2007cited by this paper
• Diagnosis and anti-infective therapy of periodontitis

  2007influential reference
• Effects of etanercept, a tumour necrosis factor‐α antagonist, in an experimental model of periodontitis in rats

  2007cited by this paper
• Novel host response therapeutic approaches to treat periodontal diseases.

  2007influential reference
• Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy.

  2007cited by this paper
• Is IL-1 a good therapeutic target in the treatment of arthritis?

  2006cited by this paper
• Safety of extended treatment with anakinra in patients with rheumatoid arthritis

  2006cited by this paper
• Effects of medications on the periodontal tissues in health and disease.

  2006cited by this paper
• Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-alpha- and dexamethasone-stimulated human periodontal ligament cells.

  2006cited by this paper
• Characterization of minocycline transport by human neutrophils.

  2006cited by this paper
• Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.

  2005cited by this paper
• Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.

  2005cited by this paper
• Lipoxin signaling in neutrophils and their role in periodontal disease.

  2005cited by this paper
• Host response modulation in the management of periodontal diseases.

  2005cited by this paper
• Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology.

  2005cited by this paper
• Topical corticosteroids in dental practice.

  2005cited by this paper
• IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα

  2003cited by this paper
• Roles of matrix metalloproteinases in tumor metastasis and angiogenesis.

  2003cited by this paper
• Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability.

  2003cited by this paper
• A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice.

  2003cited by this paper
• The role of nitric oxide in oral diseases.

  2003influential reference
• Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.

  2003cited by this paper
• Are cytokines linked to collagen breakdown during periodontal disease progression?

  2003cited by this paper
• Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• Effect of corticosteroids on human osteoclast formation and activity.

  2002cited by this paper
• Selection of antimicrobial agents in periodontal therapy.

  2002influential reference
• Systemic antibiotics in the treatment of periodontal disease.

  2002cited by this paper
• Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses?

  2001cited by this paper
• Evidence for Reactive Nitrogen Species Formation in the Gingivomucosal Tissue

  2001cited by this paper
• Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

  2001cited by this paper
• Modulating the host response as an adjunctive treatment for periodontitis

  2001cited by this paper
• p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.

  2001cited by this paper
• Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

  2001cited by this paper
• Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study.

  2001cited by this paper
• Nonsurgical periodontal therapy.

  2001cited by this paper
• How periodontal disease may contribute to cardiovascular disease.

  2000cited by this paper
• Local delivery of antimicrobial agents for the treatment of periodontal diseases.

  2000cited by this paper
• The role of immune responses in bone loss during periodontal disease.

  2000cited by this paper
• Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment.

  2000cited by this paper
• Cellular and molecular mechanisms of action of bisphosphonates

  2000cited by this paper
• Nonsurgical periodontal therapy in 2000: a literature review.

  2000cited by this paper
• Chlorhexidine-induced changes to human gingival fibroblast collagen and non-collagen protein production.

  1999cited by this paper
• Host modulation as a therapeutic strategy in the treatment of periodontal disease.

  1999cited by this paper
• Activation of Transcription Factors and IL-8 Expression in Neutrophils Stimulated with Lipopolysaccharide from Porphyromonas gingivalis

  1998cited by this paper
• Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature‐induced periodontitis in the rat

  1998cited by this paper
• Treatment of periodontal disease in diabetics reduces glycated hemoglobin.

  1997cited by this paper
• Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets.

  1996cited by this paper
• Alendronate treatment of naturally-occurring periodontitis in beagle dogs.

  1995cited by this paper
• Microbial etiological agents of destructive periodontal diseases.

  1994cited by this paper
• Topical corticosteroids and lesions of the oral mucosa

  1994cited by this paper
• [A clinico-morphological assessment of the efficacy of sodium hypochlorite in the combined therapy of periodontitis].

  1990cited by this paper
• Corticosteroid therapy and periodontal disease.

  1984cited by this paper
• [Non-surgical periodontal therapy].

  1984cited by this paper
• Corticosteroid therapy.

  1961cited by this paper
• Cellular and Molecular

  year unknowncited by this paper

• Effect of Lubanum and Potash Alum on Co-aggregation and Biofilm Formation of Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia

  2023cites this paper
• Gradual Drug Release Membranes and Films Used for the Treatment of Periodontal Disease

  2022cites this paper
• A Comparison Between Different Susceptibility Test Methods to Evaluate the Antibacterial Activity of Olibanum and Alum Against the "Red Complex" Periodontal Pathogens

  2020cites this paper
• Assessment the Effect of Some Reagents on the Planktonic Cells and Biofilms of Red Complex Periodontal Pathogens

  2020influential citation
• Elevation of the Inhibitory Action of Standard Antimicrobials (Ciprofloxacin and Chlorhexidine) by some Natural Materials against Three Periodontal Pathogens

  2020cites this paper
• An approach to Improve Therapeutic Efficacy of Doxycycline Hyclate in Treatment of Periodontitis

  2018cites this paper
• The role of three interleukin 10 gene polymorphisms (− 1082 A > G, − 819 C > T, − 592 A > C) in the risk of chronic and aggressive periodontitis: a meta-analysis and trial sequential analysis

  2018cites this paper
• COMPARATIVE SEM STUDY ON TETRACYCLINE HYDROCHLORIDE ROOT CONDITIONING: THE EFFECTS OF DIFFERENT CONCENTRATIONS AND APPLICATION TIMES

  2015cites this paper